AZN - CONSENSUS CO - AstraZeneca PLC

The AstraZeneca PLC (AZN) share price visualized below is based on the 219.96 metric. AstraZeneca PLC develops advanced treatments for cancer and orphan diseases by implementing breakthrough molecules. Its status as a global medical leader is confirmed by the creation of critical vaccines. Strict patent restrictions, the high cost of clinical trials, and effective engagement with government regulators ensure the business's resilience.

A comparative asset analysis requires benchmarking current quotes against a consensus fair value estimate, which represents the weighted average of target prices from leading investment houses. For AstraZeneca PLC (AZN), this indicator reflects market expectations regarding the success of multi-billion dollar R&D projects and the complexity of navigating stringent government regulatory filters, thereby determining the fundamental value trajectory of the shares.